Safety and Efficacy of Beclomethasone Dipropionate in Participants 4-11 Years Old With Persistent Asthma

Study Title
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma
Teva Identifier
BDB-AS-302 | 2013-004632-30
ClinicalTrials.gov Identifier
NCT02040766
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Beclomethasone dipropionate BAI | Drug: Placebo BAI | Drug: albuterol/salbutamol 90 mcg | Drug: Beclomethasone dipropionate MDI | Drug: Placebo MDI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age group
Child
Age Range
4 Years to 11 Years
Trial Duration
12/01/2013 - 03/01/2016
Phase
Phase 3

Study Type

Interventional